Treatment of Atopic Dermatitis

Dear Colleagues,

Atopic dermatitis is a chronic inflammatory skin disease. Advances in the discovery of new therapeutic targets have facilitated the development of molecules with therapeutic potential. The reality is that there is a therapeutic paradigm shift in atopic dermatitis. It is necessary to stay updated in relation to the results observed in real clinical practice experience. It is also necessary to learn about new clinical trials and new potentially therapeutic molecules. Biological therapy promises new additions, such as nemolizumab or lebrikizumab. Currently, new JAK inhibitors are being studied, although no new ones appear to be incorporated in the near future. This Special Issue, titled Treatment of Atopic Dermatitis, will attempt to cover any potentially useful treatments in this disease.

Dr. Francisco José Navarro-Triviño
Dr. Ricardo Ruíz-Villaverde
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• atopic dermatitis
• eczema
• topical treatment
• systemic treatment
• biological therapy
• JAK inhibitor
• antipruritic treatment